Search results
Zydus Life gets USFDA approval to market heart failure treatment drug
Business Standard India· 3 days agoThe approval by the US Food and Drug Administration (USFDA) is to market Sacubitril and Valsartan...
Lupin gets USFDA nod for generic medication
CNBC Awaaz· 13 hours agoThe company has received approval from the US Food and Drug Administration (USFDA) to market Topiramate extended-release capsules in the US, the drug...
USFDA red-flags desi Viagra! Indian pharmas’ erectile dysfunction drug in question over ‘fake’ data
Financial Express· 2 days agoGeneric versions of popular erectile dysfunction drugs like Viagra and Cialis have been approved in...
Alembic Pharma receives USFDA nod for Bromfenac Ophthalmic Solution
Business Standard India· 4 days agoVadodara-based generic drugmaker Alembic Pharmaceuticals on Tuesday announced that it has received...
Alembic Pharmaceuticals gets USFDA approval for Bromfenac Ophthalmic Solution - CNBC TV18
CNBC TV18· 4 days agoThe newly approved ANDA is therapeutically equivalent to the reference listed drug product, Prolensa...
Zydus Lifesciences gets USFDA nod to market chronic heart failure treatment drug - ET HealthWorld |...
The Economic Times· 3 days agoThe approval by the US Food and Drug Administration (USFDA) is to market Sacubitril and Valsartan...
Zydus Lifesciences hits all time high on USFDA nod for multiple drugs
Business Standard India· 2 days agoShares of Zydus Lifesciences zoomed up to 1.93 per cent, hitting its all time high at Rs 1203.20 per...
Zydus Life hits 52-week high on USFDA nod for Sacubitril and Valsartan
CNBC Awaaz· 2 days agoZydus Lifesciences Share Price | The company received tentative approval from the USFDA to market...
Kesoram Industries reports consolidated net loss of Rs 62.02 crore in the June 2024 quarter
Business Standard India· 3 days agoSales decline 12.01% to Rs 878.91 crore
Raymond stock trades ex-lifestyle biz; gains 4% from discovered price
Business Standard India· 2 days agoRaymond stock price today, July 11: Shares of Raymond were up 4.5 per cent to Rs 2,037 on the BSE in...